Barrett's Esophagus News and Research

Latest Barrett's Esophagus News and Research

Researchers discover new mechanism for origin of Barrett's esophagus

Researchers have discovered a new mechanism for the origin of Barrett's esophagus, an intestine-like growth in the esophagus that is triggered by chronic acid reflux and often progresses to esophageal cancer.

24 Jun 2011

Multiband mucosectomy safe and effective for treating Barrett's esophagus

An increasingly popular technique for removing lesions associated with Barrett's esophagus has been deemed a safe and effective treatment option in a study of more than 1,000 resections published this month in the European journal Endoscopy.

10 May 2011

Guided Therapeutics launches LuViva Advanced Cervical Scan

Guided Therapeutics, Inc., unveiled the new name and new industrial design for its non-invasive and painless test for the early detection of cervical precancer.

3 May 2011

Guided Therapeutics' cervical detection technology design, branding to be presented at ACOG

Guided Therapeutics, Inc., announced that it will present the new design and branding of its non-invasive and painless test for the early detection of cervical precancer at two upcoming international gynecology conferences.

28 Apr 2011

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

A new study reports that multipolar electrocoagulation in combination with acid suppression is a safe and effective method to ablate nondysplastic Barrett's esophagus over the long term.

26 Apr 2011

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

5 Apr 2011

DISCUSS survey findings highlight need to prioritize GERD dialogue

According to findings from the new nationwide DISCUSS Survey, many people surveyed report that their gastroesophageal reflux disease and/or persistent heartburn symptoms significantly disrupt their lives.

24 Mar 2011

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

BARRX Medical, Inc., a leader in developing minimally invasive medical devices to remove precancerous tissue from the gastrointestinal tract, reported today that the American Gastroenterological Association has issued the AGA Medical Position Statement on the Treatment of Barrett's Esophagus.

10 Mar 2011

GTHP provides update on FDA PMA review for LightTouch non-invasive cervical cancer test

Guided Therapeutics, Inc., today provided an update on the U.S. Food and Drug Administration review process for its premarket approval application for the LightTouch non-invasive test for the early detection of cervical pre-cancer.

8 Mar 2011

IRB approves Guided Therapeutics light-based Barrett's Esophagus detection technology for human trial

Guided Therapeutics, Inc., developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it has received Institutional Review Board approval to begin testing its light-based detection technology in humans for Barrett's Esophagus, a precursor for esophageal cancer.

8 Mar 2011

New guidelines to address major clinical issues encountered in treatment of Barrett's esophagus

Endoscopic removal of pre-cancerous cells in patients with confirmed, high-risk Barrett's esophagus is recommended rather than surveillance, according to a new "Medical Position Statement on the Management of Barrett's Esophagus," published by the American Gastroenterological Association (AGA) Institute. The medical position statement was published in Gastroenterology, the official journal of the AGA Institute.

1 Mar 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Tiny light source and sensors in endoscope may detect esophageal cancer more accurately

A tiny light source and sensors at the end of an endoscope may provide a more accurate way to identify pre-cancerous cells in the lining of the esophagus.

4 Jan 2011

NinePoint enters IP licensing agreement with Massachusetts General Hospital

NinePoint Medical, Inc., an emerging leader in the development of in vivo pathology medical devices, today announced it has entered into an intellectual property (IP) licensing agreement with Massachusetts General Hospital (MGH). Under the agreement, NinePoint has certain exclusive rights in multiple fields to 188 patents and patent applications owned by MGH.

13 Dec 2010

Digestive Disease Specialists deploys Wolters Kluwer Health's ProVation MD software

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Digestive Disease Specialists, Inc. has selected its ProVation MD software for gastroenterology procedure documentation and coding.

9 Dec 2010

FDA accepts to file PMA application for LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it was notified by the U.S. Food and Drug Administration (FDA) that the company's premarket approval application (PMA) for the LightTouch Cervical Scanner, for patients at risk for cervical cancer, is suitable for filing.

3 Dec 2010

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Cascade Technologies, Corp. announced today that, in response to significant recent attention to the Food and Drug Administration (FDA) panel evaluation of Mela Sciences' MelaFind device, the company has received a number of inquiries about its similar instrument.

20 Nov 2010

Merck wins third FOSAMAX bellwether trial

Merck & Co., Inc. today said a federal court jury in New York found in its favor in the Graves v. Merck case, rejecting the claims of a Florida woman who blamed her dental and jaw related problems on her FOSAMAX use. With today's verdict, Merck has won three of the first four bellwether cases in the FOSAMAX litigation.

20 Nov 2010

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Cascade Technologies Corp., announced today that its wholly-owned subsidiary Spectral Molecular Imaging, Inc. (SMI) has received a grant under the Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of the company's SkinSpect system for the detection of melanoma and other skin cancers.

9 Nov 2010

Guided Therapeutics receives $244,479 federal grant to advance LightTouch Cervical Scanner

Guided Therapeutics, Inc. announced that it received a $244,479 Federal grant to advance its LightTouch™ Cervical Scanner, currently under FDA review for market approval.

8 Nov 2010

Barrett's Esophagus News and Research

Latest Barrett's Esophagus News and Research

Researchers discover new mechanism for origin of Barrett's esophagus

Multiband mucosectomy safe and effective for treating Barrett's esophagus

Guided Therapeutics launches LuViva Advanced Cervical Scan

Guided Therapeutics' cervical detection technology design, branding to be presented at ACOG

Multipolar electrocoagulation is a safe, effective therapy for Barrett's esophagus

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

DISCUSS survey findings highlight need to prioritize GERD dialogue

AGA issues Medical Position Statement on Treatment of Barrett's Esophagus

GTHP provides update on FDA PMA review for LightTouch non-invasive cervical cancer test

IRB approves Guided Therapeutics light-based Barrett's Esophagus detection technology for human trial

New guidelines to address major clinical issues encountered in treatment of Barrett's esophagus

State court jury rules in favor of Merck in FOSAMAX trial

Tiny light source and sensors in endoscope may detect esophageal cancer more accurately

NinePoint enters IP licensing agreement with Massachusetts General Hospital

Digestive Disease Specialists deploys Wolters Kluwer Health's ProVation MD software

FDA accepts to file PMA application for LightTouch Cervical Scanner

Cascade reaffirms position on non-invasive detection of melanoma by SkinSpect device

Merck wins third FOSAMAX bellwether trial

Spectral Molecular Imaging awarded $190,172 QTDP grant for development of melanoma detection system

Guided Therapeutics receives $244,479 federal grant to advance LightTouch Cervical Scanner

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Barrett's Esophagus News and Research

Latest Barrett's Esophagus News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in